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Abstract 
 
Structural gender differences in bone mass – characterized by wider but not thicker bones 
– are generally attributed to opposing sex steroid actions in men and women. Recent 
findings have redefined the traditional concept of sex hormones as the main regulators of 
skeletal sexual dimorphism. Growth hormone (GH) – insulin-like growth factor-I (IGF-I) 
action is likely to be the most important determinant of sex differences in bone mass. 
Estrogens limit periosteal bone expansion but stimulate endosteal bone apposition in 
females, whereas androgens stimulate radial bone expansion in males. Androgens not 
only act directly on bone through the androgen receptor (AR) but also activate estrogen 
receptor-α or –β (ERα or ERβ) following aromatization into estrogens. Both AR and 
ERα pathways are needed to optimize radial cortical bone expansion, whereas AR 
signaling alone is the dominant pathway for normal male trabecular bone development. 
Estrogen/ERα-mediated effects in males may – at least partly – depend on interaction 
with IGF-I. In addition, sex hormones and their receptors impact on the mechanical 
sensitivity of the growing skeleton. AR and ERβ signaling may limit the osteogenic 
response to loading in males and females, respectively, while ERα may stimulate the 
response of bone to mechanical stimulation in the female skeleton.  
Overall, current evidence suggests that skeletal sexual dimorphism is not just the end 
result of differences in sex steroid secretion between sexes, but depends on gender 
differences in GH-IGF-I and mechanical sensitivity to loading as well.  
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Introduction 
 
Sex steroids are mainly synthesized by the gonads (testis and ovary), but the adrenals 
constitute an additional source (Vanderschueren et al. 2004, Callewaert et al. 2010a). Sex 
steroids are involved in the regulation of a number of important physiological processes, 
including sexual differentiation of the genitalia, sexual maturation and reproduction. Sex 
hormones also impact on skeletal homeostasis, because they add bone during puberty and 
subsequently maintain skeletal integrity, both in men and women (Riggs et al. 2002). 
However, gender differences in bone growth become apparent during puberty, with men 
reaching higher peak bone mass, greater bone size and, ultimately, a stronger skeleton 
compared to women (Garn 1970, Seeman 2001). Puberty builds a bigger but not a denser 
skeleton in males, as bone mineral acquisition in long bones occurs in proportion to the 
volume of the bone (Zamberlan et al. 1996). As a result, the volumetric BMD does not 
differ between men and women. In addition, growth during puberty also builds wider and 
slightly taller vertebral bodies in men, without sex differences in trabecular BMD 
(Gilsanz et al. 1994). As a result of these stronger structural features achieved during 
growth, the male skeleton is less susceptible to osteoporosis later in life (Seeman 2002). 
Although fewer men than women sustain fractures during aging, fragility fractures are 
common in men and are associated with a significant burden in terms of morbidity, 
mortality and economic cost to the community (Boonen et al. 2007, Khosla et al. 2008). 
Therefore, more insight into the mechanisms involved in bone mass acquisition is 
essential to improve our understanding of the pathophysiology of osteoporosis and 
osteoporotic fracture risk in men.  
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Skeletal gender differences in radial bone growth (skeletal sexual dimorphism) are 
traditionally attributed to stimulatory ‘male’ androgen action as opposed to inhibitory 
‘female’ estrogen action on periosteal bone formation. However, particularly in men, the 
mechanism of action of sex steroids on bone growth appears considerably more complex. 
Testosterone (T) – the main circulating androgen in males – not only activates the 
androgen receptor (AR), but also acts on the estrogen receptor-α or -β (ERα or ERβ) 
following aromatization into 17β-estradiol (E2) (Vanderschueren et al. 2004, Callewaert 
et al. 2010a). Experiments in animals as well as a number of case reports of men with 
either a loss-of-function mutation in ERα or aromatase deficiency provided evidence that 
estrogens play a key role in male skeletal homeostasis (Smith et al. 1994, 
Vanderschueren et al. 1997, Vidal et al. 2000, Bouillon et al. 2004, Rochira et al. 2007, 
Smith et al. 2008). In addition to sex steroids, other hormones such as growth hormone 
(GH) and insulin-like growth factor-I (IGF-I) may further contribute to the development 
of the skeletal sexual dimorphism. GH and IGF-I – the GH-IGF-I axis – are both 
primarily responsible for postnatal growth (Lupu et al. 2001). Moreover, sex steroids and 
the GH-IGF-I axis interact closely during puberty (Mauras et al. 1996), optimizing bone 
mass acquisition during pubertal growth. Finally, skeletal growth is further stimulated by 
mechanical loading (Frost 2003), which in turn may be influenced by sex hormones as 
well. In fact, mechanical loading increases bone formation in close association with 
estrogen signaling, at least in female mice (Lee et al. 2003). Thus, sex steroids, IGF-I and 
mechanical stimuli may both independently and mutually affect the acquisition of an 
optimal bone mass during puberty. In this review three major questions will be addressed: 
(1) To what extent do sex steroids or GH-IGF-I or both influence the skeletal gender 
Page 4 of 31
 5 
differences; (2) What is the relative importance of AR and ERα signaling in the 
acquisition of male cortical and trabecular bone mass; (3) Do sex steroids and their 
receptors affect the adaptive response of bone to loading? 
 
Hormonal factors involved in the development of the skeletal sexual dimorphism 
 
Evidence for a role of androgens and estrogens 
 
Puberty represents a critical growth period during which important gender differences in 
bone width and strength are established. In fact, boys develop a larger periosteal 
perimeter than girls from midpuberty onward (Seeman 2001, Kirmani et al. 2009). In 
contrast, girls experience less periosteal expansion but more endocortical apposition 
compared to boys. As a result, men not only build up wider bones but also stronger 
bones, with cortical bone further away from the neutral axis of the long bone and more 
resistant to bending. Sex hormones have traditionally been considered the primary 
mediator of skeletal sexual dimorphism in bone size and strength. This prevailing opinion 
was established by the observation of a reduced periosteal perimeter in orchidectomized 
growing male rats versus an increased periosteal circumference in ovariectomized female 
rats (Turner et al. 1990). This landmark study led to the assumption that androgens were 
stimulatory and estrogens inhibitory for male and female radial bone growth, 
respectively.  In line with this concept, a study in pubertal mouse models showed that 
androgen withdrawal – as induced by orchidectomy – decreases radial bone expansion in 
males (Callewaert et al. 2010b). Ovariectomy, on the other hand, increases radial bone 
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growth in females (Callewaert et al. 2010b). However, these hormonal effects differ in 
their timing of action, as the androgen-mediated effects occur only during later stages of 
puberty, compared to the earlier effect of estrogens and are in line with the traditional 
concept that androgens stimulate male bone size whereas estrogens limit female bone 
size. However, recent findings have partly redefined this concept, with a significant body 
of evidence pointing to a role of estrogen action in males as well. In male mice, estrogen 
deficiency on top of androgen withdrawal in male mice further reduces radial bone 
expansion, at least during the early stages of puberty (Callewaert et al. 2010b), in line 
with the concept that aromatization of androgens in estrogens also contributes to the 
skeletal gender differences (Figure 1). 
 
Evidence for a critical role of GH-IGF-I 
 
Other hormones such as GH and IGF-I also manifestly increase during puberty and are 
regarded as critical regulators of pubertal bone growth as well (Mauras et al. 1996). 
Importantly, GH-IGF-I action even appears to be the most important determinant of 
gender differences in bone mass in pubertal mice (Callewaert et al. 2010b). IGF-I levels 
are indeed higher in male versus female mice during early puberty, the time window 
during which most of the gender differences are established. Moreover, mice with a 
disrupted GH receptor (GHR) – associated with extremely low IGF-I levels – also have a 
severely reduced radial bone expansion without gender differences in radial bone growth 
(Callewaert et al. 2010b). Earlier observations of severe growth retardation in mice 
lacking GHR, IGF-I or both support the crucial role of GH and IGF-I in the control of 
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postnatal bone growth (Lupu et al. 2001) (Figure 1). Human and animal studies agree 
with this concept, as IGF-I treatment in GHR knockout (KO) mice or patients with GH 
resistance stimulates growth or even reverses the detrimental effects of GHR deficiency 
(Laron 1999, Sims et al. 2000). Beside this direct action of GH/IGF-I, however, there is 
also ample evidence for an interacting role of sex steroids and IGF-I. For instance, the 
pubertal increase in GH-IGF-I appears to be mediated by sex steroids. Neonatal T 
secretion establishes the GH secretion pattern, which – in turn – also determines 
masculinization of hepatic steroid metabolism (Jansson et al. 1985). Also, perinatal 
androgens appear a key determinant of adult bone length in males, as shown by the lower 
femoral and tibial length in androgen-deficient hypogonadal mice compared to age-
matched orchidectomized mice (Sims et al. 2006). In addition, it is now well established, 
both in humans and animals, that estrogens may interact with the GH-IGF-I axis (Juul 
2001, Venken et al. 2005). In fact, estrogen-related changes in male bone mass seem to 
be IGF-I-dependent. In male mice, estrogen-dependent skeletal changes are associated 
with lower IGF-I levels during early puberty. Similar findings have been reported in 
ERαKO mice and male rats treated with an aromatase inhibitor (Vanderschueren et al. 
1997, Vidal et al. 2000). Likewise, aromatase inhibition in adolescent boys decreases 
estrogen levels and is associated with a concomitant reduction of IGF-I levels (Mauras et 
al. 2000). Also, a recent study in cartilage-specific ERα KO mice showed that low E2 
levels during early skeletal maturation stimulate longitudinal bone growth through 
actions on the GH-IGF-I axis, independent of ERα in growth plate cartilage (Borjesson et 
al. 2010). Collectively, a significant body of evidence identifies GH/IGF-I as a critical 
regulator of skeletal gender differences. Nevertheless, the notion that sex steroids may 
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interact with IGF-I suggests that the androgens and estrogens may indirectly affect the 
skeletal sexual dimorphism as well through interaction with GH-IGF-I (Figure 1).  
 
Overall, the development of skeletal sexual dimorphism in mice resembles the human 
situation, since most of the gender differences in bone mass are established during 
puberty and associated with similar hormonal changes (Figure 1). Nevertheless, some 
differences become apparent as well. In humans, it is generally accepted that sex 
differences in bone morphology are the result of the earlier onset of puberty in girls and 
the longer duration of puberty in boys, without major differences in absolute  growth rate 
between sexes (Seeman 2002, Iuliano-Burns et al. 2009). In mice on the other hand 
absolute gender differences in periosteal and endocortical bone formation also contribute 
to the development of the skeletal sexual dimorphism (Callewaert et al. 2010b). In fact, 
periosteal and endosteal bone formation rates as determined by dynamic 
histomorphometry are higher and lower, respectively, in male versus female mice. 
Obviously, similar information on dynamic bone formation rates in humans is not 
available. Differences with respect to pubertal GH-IGF-I secretion may exist between 
humans and mice as well. In contrast with mice, peak IGF-I levels are not different 
between boys and girls. However, girls have an earlier IGF-I peak associated with the 
earlier onset of puberty (Leger et al. 2007). Overall, extrapolation of mice data on 
hormonal determinants of skeletal sexual dimorphism to the human condition should be 
handled with caution. 
 
Relative importance of androgens and estrogens during male bone growth 
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It has become increasingly clear that androgen signaling in males is far more complex 
than originally anticipated. A significant body of evidence in humans and animals has 
now firmly established that at least part of the androgen-mediated bone growth in males 
may be mediated through conversion of androgens into estrogens and subsequent ERα 
activation. In fact, aromatase-deficient men, estrogen-resistant men as well as transgenic 
mice lacking the aromatase or ERα gene all present with low bone mass (Vidal et al. 
2000, Miyaura et al. 2001, Bouillon et al. 2004, Rochira et al. 2007, Smith et al. 2008). 
Together these findings support the view that estrogens are indispensable for male 
skeletal health. Nevertheless, more conclusive evidence on the relative importance and 
differential roles of AR and ERα in cortical and trabecular bone mass accrual and 
maintenance was only recently provided by the longitudinal evaluation of male mice 
lacking both AR and ERα (Callewaert et al. 2009). This study supports AR activation as 
the sole responsible for the development and maintenance of male trabecular bone mass, 
since AR inactivation – in the presence or absence of ERα – results in a severely reduced 
trabecular bone mass with increased bone turnover (Callewaert et al. 2009). Similar 
changes – also described in other AR knockout (KO) models (Kawano et al. 2003, 
Venken et al. 2006) – are main features of hypogonadal osteoporosis as well (Finkelstein 
et al. 1989). Along the same line, testosterone treatment restores orchidectomy-induced 
trabecular bone loss in male mice (Venken et al. 2006), adding further evidence to the 
concept of AR signaling as a critical regulator of the development of normal male 
trabecular bone mass. On the other hand, administration of an aromatase inhibitor in 
ARKO and orchidectomized mice has no effect on trabecular bone (Venken et al. 2006), 
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suggesting that residual ERα activation fails to restore or compensate AR-mediated bone 
loss. This lack of a role of ERα during male trabecular bone growth sharply contrasts 
with the important role of ERα in female mice (Lindberg et al. 2001), or with the 
pharmacological effect of (supraphysiological) estrogen administration in 
orchidectomized male mice (Vandenput et al. 2001). Moreover, various studies even 
report an increased trabecular bone mass in ERαKO mice (Vandenput et al. 2001, Sims 
et al. 2003, Callewaert et al. 2009), which could be attributed to higher androgen levels 
acting through the AR. In line with this assumption, surgical castration or antiandrogen 
treatment of ERαKO mice normalizes the trabecular bone mass in these mice (Vandenput 
et al. 2001, Sims et al. 2003). Together, these observations clearly define AR and ERα 
activation as the primary determinant of trabecular bone development in male and female 
mice, respectively.  
In contrast with their role in trabecular bone, AR and ERα are both required for optimal 
stimulation of male cortical bone mass in male mice. In fact, AR-ERα ‘double’ KO mice 
have lower cortical bone mass compared with either ARKO or ERαKO mice alone 
(Callewaert et al. 2009). Likewise, administration of an aromatase inhibitor further 
reduces cortical bone mass in orchidectomized mice (Callewaert et al. 2010b). In line 
with these findings, testosterone action on periosteal bone formation and cortical 
thickness is blunted by an aromatase inhibitor in orchidectomized mice (Venken et al. 
2006). The importance of aromatization of androgens into estrogens for cortical bone 
expansion is also supported by observations in humans. Cortical bone dimensions failed 
to enlarge in an adolescent aromatase-deficient boy despite supranormal testosterone 
concentrations (Bouillon et al. 2004). In this patient, estrogen treatment substantially 
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increased bone size, suggesting that optimal cortical bone expansion requires activation 
of both AR and ERα, not only in mice but also in humans. Beside ERα, estrogens might 
also activate ERβ. In contrast with female ERβKO mice – which show an increased 
cortical bone mineral content and cross-sectional area – ERβ does not appear to play any 
role in male skeletal growth, since male ERβKO do not display a bone phenotype 
(Windahl et al. 1999, Vidal et al. 2000, Sims et al. 2002). Thus, ERα but not ERβ 
appears to mediate estrogen actions during male skeletal growth. Although AR activation 
is the dominant pathway of androgen signaling for male trabecular bone growth and 
maintenance, it would seem therefore that AR and ERα activation are both required to 
optimize cortical bone growth (Figure 2). 
 
Androgen signaling and the mechanical sensitivity of the male skeleton 
 
Functional response of bone to loading 
 
Mechanical loading has a major impact on skeletal growth. The change in body weight 
and resulting mechanical stimulation of the skeleton during puberty are substantial. Since 
overall growth rate is higher in males than females, the male skeleton encounters higher 
mechanical demands. It is therefore tempting to speculate that this higher load-bearing in 
males also stimulates bone growth to a greater extent than in females, as reflected by 
more periosteal bone formation during puberty (Callewaert et al. 2010b). The stimulatory 
role of mechanical loading and physical activity on bone expansion has been well 
documented in numerous experimental and clinical studies. A range of non-invasive axial 
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loading models, using various animal models subjected to different exercise regimens, 
have provided insights in the anabolic response of bone to loading (Mosley et al. 1997, 
Mosley & Lanyon 1998, Hsieh & Turner 2001, Srinivasan et al. 2002). Overall, these 
animal studies have consistently indicated that mechanical loading influences the 
morphology of growing bone by increasing bone formation more than resorption. In 
humans, most evidence is derived from cross-sectional observations. For instance, tennis 
players have been shown to have larger cortical thickness in the dominant playing arm 
compared with the nonplaying arm (Bass et al. 2002). Moreover, the increase in bone 
mass in elite gymnasts persists after retirement, suggesting that the beneficial effects of 
loading may induce lifelong benefits to bone strength (Bass et al. 1998). Similar findings 
have been obtained in a few longitudinal studies, reporting significant side-to-side 
differences in bone size and strength in tennis players 1.5-3 years after retirement 
(Haapasalo et al. 2000). Yet, the assumption that skeletal benefits obtained from exercise 
may be maintained into older age remains uncertain, as unequivocal longitudinal 
evidence is currently lacking. The timing and duration of exercise also influences the 
response to loading in humans. In fact, different responses to loading have been reported 
in pre-, peri- and postpubertal tennis players. In female players, loading before puberty 
and during early puberty enhances periosteal bone formation and bone strength, whereas 
loading during late puberty bone is mainly accumulated at the endocortical bone surface 
without major changes in bone strength (Bass et al. 2002). In male players, on the other 
hand, periosteal expansion in response to loading is most pronounced in pre- and 
peripubertal boys and then tends to plateau (Ducher et al. 2009). It would seem therefore 
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that pubertal growth and sex hormones appear to influence the adaptive response to 
exercise, and this interaction may be different in boys and girls.  
 
Interaction of sex steroids and mechanical loading 
 
Sex steroids may also modulate the response of bone to mechanical stimulation. This 
hypothesis originates from rodent studies, showing that female rats have more bone than 
male rats relative to body weight (Saville 1969, Wang et al. 2003). A study in human 
observed a similar evolution, as the increase in bone mass relative to muscle mass is 
greater in girls compared with boys during puberty (Schiessl et al. 1998), even after 
adjustment for fat mass (Ferretti et al. 1998). These observations suggest that estrogens 
alter the mechanosensitivity of bones, so that more bone is accumulated than is needed 
mechanically. Moreover, it has been hypothesized that estrogen withdrawal during 
menopause impairs the mechanically adaptive mechanism, and hereby contributes to 
postmenopausal bone loss and the development of osteoporosis (Lanyon & Skerry 2001). 
Exercise, however, is generally believed to stimulate periosteal bone formation, whereas 
estrogen appears to have an inhibitory effect in females – at least in mice (Callewaert et 
al. 2010b). For instance, prepubertal female tennis players with low estrogen 
concentrations show a more favorable periosteal response compared to postpubertal girls 
with high estrogen levels (Bass et al. 2002). Concurrently, estrogen supplementation in 
male rats appears to suppress the periosteal response to mechanical loading (Saxon & 
Turner 2006). According to in vitro as well as in vivo rodent studies, sex steroid signaling 
and mechanical loading may also share common signaling pathways. Estrogen and 
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mechanical strain stimulate proliferation independently in osteoblast-like cells derived 
from male and female rat as well human osteoblasts (Damien et al. 2000, Cheng et al. 
2002). Nevertheless, estrogen receptor modulators and antagonists block the increase in 
proliferation in response to mechanical strain, whereas DHT and AR activation 
apparently are not involved. These findings suggest that ERs, but not AR, influence the 
response to strain. As a proof of this concept, periosteal bone formation in response to in 
vivo ulna loading is significantly reduced in female ERαKO mice (Lee et al. 2003). In 
contrast, disruption of ERβ increases periosteal bone formation following loading in 
female but not male mice (Saxon et al. 2007). Together, these findings clearly indicate 
that sex hormone signaling interferes with the mechanical response to loading, at least in 
female mice, with ERα and ERβ having antagonistic effects. A recent report also 
investigated the role of sex steroid receptors in the mechanical sensitivity of the male 
skeleton (Callewaert et al. 2010c). This study suggests that ERα does not interfere with 
the adaptive response in males, which is in sharp contrast with the above-mentioned 
crucial role of ERα in females. Indeed, periosteal bone formation is similarly increased 
following loading in male ERαKO compared with WT mice. The apparent gender-
dependent importance of ERα in mice is also supported by observations in humans, since 
puberty and sex steroid exposure influence the mechanical bone response differently in 
boys and girls (Bass et al. 2002, Ducher et al. 2009). In addition, AR activation may even 
limit the response to mechanical stimulation,  since AR deletion – both in the presence 
and absence of ERα – increases the periosteal bone response to loading (Callewaert et al. 
2010c). AR signaling not only increases periosteal bone formation following loading, but 
also lowers SOST and sclerostin expression (Callewaert et al. 2010c). Sclerostin, which 
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is encoded by the SOST gene, is  the  principal  osteocyte-specific inhibitor of bone 
formation known to antagonize Wnt/β-catenin signaling (Poole et al. 2005, ten Dijke et 
al. 2008). The role of osteocyte-specific sclerostin signaling in mechanotransduction has 
previously been demonstrated in both loading and unloading conditions (Robling et al. 
2008, Lin et al. 2009). Therefore, AR signaling may interfere with the inhibiting effect of 
sclerostin signaling on bone formation. In conclusion, in vitro and in vivo animal data as 
well as observations in humans have indicated that estrogen may modulate the effects of 
loading in females. In fact, ERα activation is required for the full osteogenic response to 
loading, whereas ERβ activation appears to inhibit periosteal bone formation following 
loading in females. In contrast with female mice, ERα and ERβ apparently are not 
involved in the response to loading in male mice. AR signaling, on the other hand, limits 
the anabolic response to mechanical loading in male mice, possibly through interaction 
with sclerostin signaling (Figure 3).   
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Conclusion 
 
GH/IGF-I action, more than sex steroid action, appears to be the primary determinant of 
gender differences in pubertal bone growth, which – in turn – may be influenced by sex 
hormones (e.g. neonatal imprinting). Beside GH/IGF-I, estrogens limit periosteal bone 
expansion but stimulate endocortical apposition in females. In males, both androgens and 
estrogens stimulate periosteal bone expansion and hence cortical bone growth during 
puberty. However, estrogen action on male cortical bone may at least partly be explained 
by concomitant changes in IGF-I (Figure 1). In contrast with its role in cortical bone 
growth, AR activation alone is sufficient for the development of trabecular bone mass in 
males (Figure 2). Finally, sex steroids and their receptors also impact on the mechanical 
sensitivity of the male and female skeleton. AR and ERβ signaling limit the osteogenic 
response to mechanical loading in male and female mice, respectively. ERα activation, 
on the other hand, stimulates bone formation in response to mechanical loading in female 
but not male mice (Figure 3). Therefore, skeletal sexual dimorphism is not only 
determined by androgen action in males and estrogen action in females, respectively, but 
also by complex gender- and time-specific interactions between sex hormones, GH-IGF-I 
and mechanical loading. 
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Figure legends 
 
Figure 1. Insulin-like growth factor-I (IGF-I) is the primary determinant of the skeletal 
sexual dimorphism, which develops during puberty. Male androgen action also 
contributes to the larger male bone size by stimulating radial bone expansion mostly 
during late puberty. Male estrogen action has early stimulatory effects on periosteal bone 
expansion, but may be regulated through changes in IGF-I levels. In female mice 
estrogens limit radial bone expansion already during early puberty. 
 
Figure 2. Differential roles of AR (androgen receptor) and ERα or –β (estrogen receptor-
α or -β) signaling in the accrual of an optimal cortical and trabecular bone mass in male 
and female mice. (T = testosterone; E2 = 17β-estradiol)  
 
Figure 3. Interaction of sex steroids and their receptors with the adaptive response of 
bone to mechanical stimulation. In female mice, ERα activation is required for the full 
osteogenic response to loading, while ERβ activation inhibits it. In contrast, ERα or ERβ 
activation in male mice seems not important for an optimal response to mechanical 
stimulation. AR activation on the other hand limits the mechanical sensitivity of the male 
skeleton, potentially through downregulation of SOST signaling. (E2 = 17β-estradiol; T = 
testosterone; ERα = estrogen receptor-α; ERβ = estrogen receptor-β; AR = androgen 
receptor) 
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